Windtree Therapeutics Inc (WINT)
3.571
-0.07
(-1.90%)
USD |
NASDAQ |
May 31, 16:00
3.57
0.00 (0.00%)
After-Hours: 20:00
Windtree Therapeutics Free Cash Flow (Quarterly): -2.947M for March 31, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.947M |
| December 31, 2023 | -3.567M |
| September 30, 2023 | -3.869M |
| June 30, 2023 | -3.497M |
| March 31, 2023 | -2.519M |
| December 31, 2022 | -3.38M |
| September 30, 2022 | -4.099M |
| June 30, 2022 | -5.268M |
| March 31, 2022 | -6.718M |
| December 31, 2021 | -5.105M |
| September 30, 2021 | -5.384M |
| June 30, 2021 | -7.406M |
| March 31, 2021 | -6.048M |
| December 31, 2020 | -4.803M |
| September 30, 2020 | -8.271M |
| June 30, 2020 | -7.05M |
| March 31, 2020 | -5.482M |
| December 31, 2019 | -5.521M |
| September 30, 2019 | -3.727M |
| June 30, 2019 | -6.773M |
| March 31, 2019 | -8.833M |
| December 31, 2018 | -6.191M |
| September 30, 2018 | -3.278M |
| June 30, 2018 | -3.766M |
| March 31, 2018 | -2.546M |
| Date | Value |
|---|---|
| December 31, 2017 | -4.808M |
| September 30, 2017 | -3.376M |
| June 30, 2017 | -5.533M |
| March 31, 2017 | -7.352M |
| December 31, 2016 | 60.14M |
| September 30, 2016 | -8.376M |
| June 30, 2016 | -9.139M |
| March 31, 2016 | -9.322M |
| December 31, 2015 | -7.596M |
| September 30, 2015 | -7.527M |
| June 30, 2015 | -9.731M |
| March 31, 2015 | -9.108M |
| December 31, 2014 | -10.18M |
| September 30, 2014 | -10.62M |
| June 30, 2014 | -10.36M |
| March 31, 2014 | -10.78M |
| December 31, 2013 | -10.44M |
| September 30, 2013 | -10.06M |
| June 30, 2013 | -10.21M |
| March 31, 2013 | -10.36M |
| December 31, 2012 | -9.106M |
| September 30, 2012 | -9.926M |
| June 30, 2012 | -8.804M |
| March 31, 2012 | -5.684M |
| December 31, 2011 | -5.542M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-8.271M
Minimum
Sep 2020
-2.519M
Maximum
Mar 2023
-5.072M
Average
-5.186M
Median
Free Cash Flow (Quarterly) Benchmarks
| Lexicon Pharmaceuticals Inc | -55.13M |
| AIM ImmunoTech Inc | -4.865M |
| Perspective Therapeutics Inc | 4.776M |
| Protalix BioTherapeutics Inc | 3.59M |
| Armata Pharmaceuticals Inc | -10.83M |